Mad in America is a webzine devoted to rethinking psychiatry’s current “disease model” for diagnosing and treating psychiatric disorders. This Parent Resources section is designed to provide information and resources for parents who wish to explore alternatives to conventional, drug-based psychiatric care for children and youth.
CAUTION: Spin Ahead! There is No Evidence That Psychostimulants Reduce the Risk for Infection with COVID-19
Parents and adult children:
MIA is seeking to interview people with lived experience as an inpatient, on AOT, under guardianship, or otherwise engaged with the mental health system who have been discouraged or prevented from voting because of a psychiatric diagnosis. MIA Reports is doing an in-depth article on this subject. If interested, please contact editor Miranda Spencer at [email protected]
Psychiatric Drug Info
Did you know:
- That longer-term studies of children given a diagnostic label of ADHD have found worseoutcomes for medicated youth?
- In a large NIMH study, researchers concluded that few youth “benefit long-term” from antipsychotics (neuroleptic drugs)?
- That marijuana, stimulants, and antidepressants increase the risk that a youth will receive a diagnostic label of bipolar disorder?
Research on psychotropic use in children and adolescents
- Stimulants for children with a diagnostic label of ADHD
- Antidepressants for children with a diagnostic label of depression/anxiety
- Antipsychotics (neuroleptics) for children with a diagnostic label of psychosis, bipolar disorder, and more
Research on non-pharmacological treatments